Trial Profile
A Study to Evaluate the Efficacy of Artemether/lumefantrine as the First-line Therapy in Patients with Uncomplicated Plasmodium falciparum Infections
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary)
- Indications Malaria
- Focus Therapeutic Use
- 23 Dec 2015 New trial record